We determined the nucleotide (nt) and amino acid (aa) heterogeneities of three distinct regions of the human cytomegalovirus (CMV) genome for 46 low-passage CMV isolates from four different patient populations (congenitally infected infants, children attending day-care centers, renal transplant recipients, and human immunodeficiency virus-infected individuals) and for two laboratory strains (CMV Ad169 and Towne). 
The human cytomegalovirus (CMV) genome consists of 230 to 235 kbp of double-stranded DNA (4) and contains more than 200 predicted open reading frames (5) . Like other herpesviruses, CMV induces latency, and the virus may become reactivated with immunosuppression. Reinfection with new genetically distinct CMV strains is prevalent, especially among transplant recipients (7) . In immunocompromised hosts, primary or reactivated CMV infection or reinfection may result in a variety of clinical manifestations and may sometimes cause life-threatening CMV disease (2) .
Early diagnosis of CMV infection is important if the development of CMV disease is to be prevented. Immunosuppressed patients might especially benefit from prompt institution of preemptive antiviral therapy (25) . PCR has been widely used for the rapid diagnosis of CMV infection. Although PCR is rapid and sensitive in most cases, we have reported failure to detect CMV DNA from some CMV strains due to primer and target mismatches (27) .
It has previously been shown by restriction fragment length polymorphism analysis that a number of CMV strains are circulating in the general population and that each of them displays its own restriction fragment length polymorphism pattern (12, 13) . The extent to which the diversity found among human CMV strains is reflected in biological and functional differences is unknown at present. Little information about sequence variation within different CMV genes is available since only a few genes have been extensively studied. Previous studies indicate that sequence variation among CMV strains frequently occurs even in gene regions considered to be highly conserved (6, 8, 10) .
We have studied three functionally important CMV genes, all of which are expected to be highly conserved: the IE1 region or the major immediate-early (MIE) gene region, the DNA polymerase gene region, and the glycoprotein B (gB) gene region. The MIE gene encodes the MIE protein (ppUL123), which already appears in infected cells after 1 h and has an important function in the regulation of CMV genes (19) . The CMV DNA polymerase gene, encoded by the open reading frame UL54, plays an important role in DNA replication (19) . The major envelope glycoprotein gB (gpUL55) is involved in cell-to-cell transmission of CMV and is the dominant target for neutralizing antibodies (19) .
Our aims were to assess the nucleotide (nt) sequence variations in CMV isolates from both immunocompetent and immunocompromised individuals in comparison with the sequences of the laboratory strains Ad169 and Towne and to define genomic targets suitable for primer selection when constructing new diagnostic PCR systems for optimal detection of CMV in clinical samples from all patient populations.
MATERIALS AND METHODS
Clinical specimens. Leukocytes separated from EDTA-anticoagulated blood from 12 renal transplant recipients and urine samples from a total of 34 patients, including 10 congenitally infected infants (ages, 0 to 14 days), 10 children (ages, 2 to 6 years) attending two different day-care centers, and 14 human immunodeficiency virus (HIV)-infected individuals without an obvious relation were inoculated onto human embryonic fibroblasts (HEFs). The CMV isolates were passaged one to four times in HEF cells and were stored at Ϫ70°C until PCR amplification for DNA sequencing.
Thirty selected specimens (23 EDTA-anticoagulated plasma samples, 5 bronchoalveolar lavage specimens, and 2 urine specimens) that had been stored at Ϫ70°C were used for a preliminary evaluation of a new nested PCR with primers from the CMV DNA polymerase gene region. The specimens were selected from a previous study and had been CMV culture positive but CMV PCR negative with our standard MIE primers and by alkaline treatment for DNA extraction (27) .
Sample preparation for PCR. For sequencing, 10 l of tissue culture medium from infected fibroblasts was added directly to the PCR mixture. For a minority of samples, DNA extraction with phenol-chloroform and ethanol precipitation was performed to achieve successful CMV DNA amplification. For diagnosis, CMV DNA extraction was performed with the QIAamp blood kit (QIAGEN) according to the manufacturer's instructions.
PCR amplification. The nested PCR systems used for sequencing and diagnosis are listed in Table 1 , including the optimal conditions for buffers, the primers, and the times and temperatures during the cyclings in the different assays (3, 27) . For the second primer pair, which was used for sequencing, one primer (MIE4, POL2, or gBF1) was biotinylated, while the other primer (MIE3, POL1, or gBE1) contained a 21-nt handle sequence complementary to the sequencing primer. After amplification, 10 l of the amplified product was electrophoresed on a 3% agarose gel containing ethidium bromide, and the gels were subsequently photographed under UV illumination. False-positive results due to contamination were excluded by analyzing water as every second sample. Crude lysates of diluted HEF cells infected with human CMV Ad169 were used as positive controls.
Solid-phase DNA sequencing. The CMV DNA in PCR-positive samples was sequenced as described by Wahlberg et al. (24) by using an AutoRead T7 sequencing kit (Pharmacia Biotech). Briefly, the double-stranded PCR templates were immobilized on magnetic beads (Dynabeads M-280 Streptavidin; Dynal AS, Oslo, Norway) and were subsequently converted into single strands by alkaline treatment. The annealing buffer and a fluorescing sequencing primer were added, and after heating to 65°C and cooling to room temperature, the beads with the immobilized single-stranded template DNA were transferred to a 96-well plate. Extension buffer and T7 DNA polymerase were added, and the mixture was dispensed into four wells, whereupon the dideoxynucleotides (ddATP, ddCTP, ddGTP, and ddTTP) were added. After incubation for 5 min at 37°C, stop solution was added. The mixture was heated to 92°C just prior to loading of the gel. The fluorescing bands were read on a 6% polyacrylamide gel with an automated laser fluorescence sequencing apparatus (Pharmacia LKB), and the nt and amino acid (aa) sequences were deduced.
Comparison of CMV gene sequences. The length of the MIE exon 4 gene is 1,218 bp (nt positions 1505 to 2722) (1), and it encodes 406 aa. The sequence of nt positions 1702 to 1982 (281 bp encoding aa positions 152 to 244) was determined for each of the 46 isolates and the laboratory strains (Ad169 and Towne). The CMV DNA polymerase gene consists of 3,726 bp (1,242 aa) (16) . The CMV DNA polymerase has eight conserved regions (A and I to VII) (11, 14, 26) with high degrees of homology to other DNA polymerases (22) . The sequence from bases 2797 to 3046 (250 bp encoding aa 713 to 795) (16) including the major part of region II (aa 696 to 742) and the whole of region VI (aa 771 to 790) was determined. In total, 50 of the 83 aa sequenced within the DNA polymerase are located in conserved regions. The gB gene consists of 2,721 bp (907 aa) (9, 20) , and the sequence of gB from bases 1698 to 1884 (187 bp encoding aa 567 to 628) was analyzed. The major neutralizing epitope of gB consists of aa 552 to 635 (23) .
Phylogenetic tree analysis. Phylogenetic tree analysis of the nucleotide sequences was conducted with the GCG package by using the distance matrix and Growtree based Neighbor-joining tree building method and the Jukes-Cantor one-parameter substitution model.
Nucleotide sequence accession numbers. The GenBank accession numbers for the reported sequences are AF099506 to AF099643. The sequences of fragments of Ad169 and Towne that were sequenced were identical to previously published sequences (1, 9, 15, 16, 20) . The published sequence differences between the Ad169 and Towne strains within the MIE exon 4 gene region at a single nt position (nt position 1952) (1), 6 nt positions within the DNA polymerase gene (nt positions 2810, 2868, 2891, 2900, 2954, and 2978) (15, 16) , and 4 nt positions within the gB gene (nt positions 1698, 1734, 1794, and 1866) (9, 20) were confirmed.
Analyses of the sequences of the three gene fragments in the different isolates revealed a number of nt changes at several positions. Table 2 presents the number of nt substitutions in the sequences of all 46 isolates as well as in those of isolates from each of the four patient populations compared to the sequence of strain Ad169. We found that the MIE gene was the most variable gene region, and 34 of 281 bp sequenced (12.1%) had nt variations in one or more isolates. In comparison, nt variations occurred in the DNA polymerase gene at 18 of 250 positions (7.2%) and in the gB gene at 13 of 187 positions (7%). Comparisons between the 46 isolates and the Towne strain revealed nt variations of the same magnitude as those for Ad169, and variations were found at 12.1, 8, and 7.5% of the positions of the MIE, DNA polymerase, and gB genes, respectively.
The degrees of homology between the sequence of the single most variable patient strain and that of strain Ad169 for each gene fragment were 97.9% for the MIE gene, 96.4% for the CMV DNA polymerase gene, and 96.3% for the gB gene.
Differences in the frequencies of nt sequence variations in isolates from the different patient populations were seen (Table 2). Thus, isolates from children attending two different day-care centers had the least nt sequence variation, with nt sequence homology within the MIE gene of 96.4% compared to the sequence of Ad169. The nt sequence homology compared to the sequence of Ad169 for the isolates from the three other groups was only 90% for this gene region. A greater nt sequence homology and no significant differences in sequence homologies between isolates from the different groups were found for the other two gene regions.
The total number of nt sequence variations within each gene was determined as the total number of nt substitutions occurring within the sequenced isolates divided by the total number of nt positions sequenced. The total nt sequence homology for all 46 isolates compared to the sequence of the Ad169 strain was 96.7% for the MIE gene, 97.2% for the CMV DNA polymerase gene, and 98.9% for the gB gene ( Table 2) .
Definition of new reference sequences. The laboratory strains Ad169 and Towne displayed greater nt sequence variations than the wild-type isolates, which might indicate that Ad169 and Towne are less representative of the CMV strains that are now circulating in society. Reference sequences were determined by using the sequence data for the wild-type isolates obtained in the present study. For nt substitutions occurring in Ն50% of the CMV isolates, the sequences were considered the consensus sequence. The defined sequences are suggested to be used as new reference sequences (Fig. 1) . By this definition, 4 of the 34 nt substitutions found within the MIE gene (when compared to the sequence of the Ad169 strain) were now considered to represent the consensus sequence. In the same manner, 8 of the 18 nt substitutions and 1 of the 13 nt substitutions within the DNA polymerase and gB genes, respectively, were considered to represent the consensus sequence. When the sequences of the isolates were compared to that of the Towne strain instead, 3 of the 34 nt substitutions in the MIE gene, 6 of the 20 nt substitutions in the DNA polymerase gene, and 1 of the 14 nt substitutions in the gB gene were considered to represent the consensus sequence. A comparison of the new reference sequences and the sequences of the 46 isolates whose sequences were determined showed that the MIE gene remained the most variable gene region since nt substitutions occurred at 30 of 281 positions (10.7%), whereas substitutions occurred at 11 of 250 positions (4.4%) within the DNA polymerase gene and 12 of 187 positions (6.4%) within the gB gene (Table 3) .
When the nt sequences for all isolates were compared to the new reference sequences, the homologies within the MIE, CMV DNA polymerase, and gB genes were 97.7, 99.7, and 99.2%, respectively (Table 3) .
Phylogenetic tree analysis. Phylogenetic tree analysis was used to compare the genetic distances for all 46 isolates, the 2 laboratory strains (Ad169 and Towne), and the suggested new reference sequences. Figure 2 shows the trees generated by using sequences from the MIE, DNA polymerase, and gB gene regions. The trees demonstrate, like the nt sequence variation data, that the most genetic drift has occurred in the MIE gene (Fig. 2C) . aa alteration within CMV isolates. In this study 93 aa (aa positions 152 to 244) within the MIE exon 4 gene, 83 aa (aa positions 713 to 795) within the DNA polymerase gene, and 62 aa (aa positions 567 to 728) within the gB gene were deduced from the nt sequences for all isolates. We found aa alterations at 12 positions (13%) within the MIE gene and at three positions (5%) within the gB gene, while the CMV DNA polymerase gene was highly conserved at the aa level since the sequences of all 46 isolates whose sequences were determined were identical to the sequence of Ad169 (Fig. 1) . When the sequences of the CMV isolates were compared to the new reference sequences instead of the sequence of Ad169, a single aa alteration at position 178 (S3T) within the MIE gene was found in Ն50% of the isolates and was therefore considered the consensus sequence, while the other aa alterations within the MIE and gB genes occurred at the same positions compared with the sequence of Ad169.
A total of 35 of 46 isolates (76%) displayed a total of 143 aa alterations at 12 positions in the MIE gene compared to the sequence of Ad169 (Fig. 1) . The majority of alterations, 88 of 143 (62%), were found among 10 renal transplant patients and 11 HIV-infected individuals (Fig. 1) . The number of aa alterations found in the individual isolates varied between two and five (average, 3.1).
Sequencing of the gB gene revealed that 12 of 46 isolates (26%) possessed a total of 18 aa alterations at three positions within the major neutralizing epitope compared to the sequence of Ad169 (Fig. 1) . The majority, 15 of 18 (83%), of aa alterations occurred in isolates from five congenitally infected infants (50%) and in four isolates from children attending day-care centers (40%) (Fig. 1) .
Conserved CMV DNA regions suitable for use as PCR primer sequences. The sequence data obtained in this study were used to design sets of primers for nested PCR directed against the most highly conserved MIE, CMV DNA polymerase, and gB gene regions identified. With the use of the computer program OLIGO, we selected four primer sequences from each of the three gene regions for potential use in a diagnostic nested PCR (Table 1 and Fig. 1 ). The selected primer sequences were carefully analyzed for optimal energy, GC content, and the risk of primer dimer formations. Examination for nt homology to the human herpesviruses, herpes simplex virus types 1 and 2, human herpesvirus 6, Epstein-Barr virus, and varicella-zoster virus excluded cross-reactivity with the new primers.
The selected primer sequences from the CMV DNA polymerase gene region (new CMV POL) ( Table 1) were validated for their potential use in a nested PCR assay for the detection of CMV DNA in clinical specimens. Thirty specimens (23 EDTA-anticoagulated plasma specimens, 5 bronchoalveolar lavage specimens, and 2 urine specimens) were analyzed with our standard MIE primers and the new POL primers. The QIAamp blood kit was used for DNA extraction. CMV DNA was demonstrated in 13 of 30 specimens (10 plasma specimens, 2 bronchoalveolar lavage specimens, and 1 urine specimen) with the MIE primers and in 24 of 30 specimens (20 plasma specimens, 3 bronchoalveolar lavage specimens, and 1 urine specimen) with the POL primers. The detection limit of the standard PCR with the MIE primers is at least 5 to 10 fg of CMV DNA, whereas the detection limit of the new PCR with the POL primers is 1 to 10 fg of CMV DNA. These findings indicate that the new primer sequences from the CMV DNA polymerase gene region might be more powerful than the standard MIE primers for diagnostic purposes. However, their sensitivity and specificity need to be further evaluated. The selected new gB and MIE primers still remain unvalidated.
DISCUSSION
In this study independent clinical CMV isolates selected from four clinically different patient populations were analyzed for their degrees of sequence variation and for their phylogenetic relationships. Regions from the following conserved genes with functional properties were selected: the MIE gene (MIE exon 4), the DNA polymerase gene, and the gB gene. So far, only a few CMV genes have been sequenced, and most studies have concentrated on isolates from immunosuppressed patient populations (3, 6, 8, 17) . The MIE and gB gene regions have been studied previously (1, 3, 6, 8-10, 17, 20) , while little information is available for the DNA polymerase gene (15, 16, 18) . New reference CMV gene sequences, based on the sequencing data that have been obtained, are proposed as substitutes for the high-passage laboratory CMV strains Ad169 and Towne. It was also possible to identify new primer sites within highly conserved gene regions for the identification of CMV DNA from infected patients.
The MIE gene was the most variable gene region, and the frequent nt substitutions were scattered at several positions throughout the whole gene region, especially among isolates from kidney transplant recipients and HIV-infected individuals (Fig. 2) . Within the DNA polymerase gene region, the nt substitutions appeared to be clustered at fewer positions within isolates from all patient populations, and within the gB gene a clustered distribution of nt substitutions at only a few distinct positions was found, especially among isolates from congenitally infected infants and children attending day-care centers ( Fig. 1) .
These findings might be of importance for diagnostic purposes since, according to the literature, most laboratories use primer sequences from the MIE gene region in their diagnostic PCR assays (3, 6, 17, 27) . Also, the majority of samples analyzed in routine viral diagnostic laboratories are obtained from immunocompromised patients, since these patients benefit most from a rapid diagnosis of CMV infection and subsequent preemptive antiviral therapy. Furthermore, we have previously reported the failure to detect CMV DNA in clinical samples by PCR using our standard primers from the MIE exon 4 gene region (27) . Analysis of the sequence of this gene region showed primer and target mismatches at four nt positions within one of the inner MIE primers and at six nt positions and one nt position, respectively, within the outer primers. These mismatches might explain the previously reported failure to detect CMV DNA.
Considering these facts, we found it necessary to define new primer sequences based on the sequence data obtained for the wild-type isolates. The selection of primer sequences from within the MIE gene sequence was hampered by the frequent nt substitutions occurring throughout the gene. Since the nt substitutions within the DNA polymerase and gB genes were fewer and were more clustered at distinct positions, it was easier to find conserved regions of DNA suitable as primer targets for PCR amplification. The outer reverse CMV POL primer CMVP2 was chosen from a region (nt positions 3071 to 3089) which is located outside the sequenced regions of all isolates whose sequences were compared. The selected region was considered to be more optimal according to the OLIGO analysis. Furthermore, the sequences of the majority of isolates had been sequenced throughout this region. Mutations in the CMV DNA polymerase gene associated with antiviral resistance have been described and should be considered at primer selection. However, only a few mutations conferring antiviral resistance have been mapped to region II (21) .
The primers from the more conserved DNA polymerase gene region were validated, and we found that the new PCR with POL primers was more sensitive for the detection of CMV DNA in clinical specimens than our standard PCR with MIE primers. In fact, use of the new PCR with POL primers and QIAamp DNA extraction instead of PCR with MIE primers reduced the proportion of previously nonidentifiable CMV strains by nearly 50%.
New reference strain sequences based on the data obtained for the wild-type isolates are suggested in the present study. These sequences are more closely related to those of CMV isolates circulating in society today compared to those of the old and highly passaged Ad169 and Towne strains. Comparison of the nt sequence variations within the MIE genes from the small number of isolates obtained from the different patient populations with the sequence of the Ad169 strain and the sequences of the new reference strain revealed that the least genotypic variation was found in isolates obtained from children attending day-care centers compared to that in isolates from the other patient populations. For the DNA polymerase and gB genes, no major difference in nt sequence homology between isolates from the patient populations and the Ad169 and the new reference strains was found (Tables 2  and 3) .
The phylogenetic tree analysis also supported the findings that the MIE gene sequences are more heterogeneous than the DNA polymerase and gB gene sequences and the fact that no close genetic relationship exists between wild-type isolates and laboratory strains Ad169 and Towne. Subdivision of the CMV strains from the different patient populations on the basis of the phylogenetic tree analysis was not possible.
The fact that none of the nt substitutions within the DNA polymerase gene led to aa alterations might reflect the strong functional conservation within this gene due to its importance during viral replication. nt substitutions within the gB and MIE exon 4 gene regions led to three (5%) and 12 (13%) aa alterations, respectively. The aa alterations at positions 585 and 613 within the gB gene have been described previously by Chou and Dennison (8) , while the aa alteration F3S at position 619 found in a single isolate in the present study has not been reported previously. Within the MIE exon 4 gene region the aa alterations at positions 175, 176, 178, and 198 and the aa alteration I3V at position 212 have previously been reported by Chou (6) , while the alterations at positions 190 and 205 and the R3K or N substitution at position 201 were previously described by Brytting et al. (3) . In this study another six aa alterations that have not been reported previously were found, namely, V3L at position 177, A3V at position 193, R3T at position 201, M3I at position 207, I3M at position 212, and Q3B at position 230. gB is continuously subjected to the immune response, and the variation in the gB gene sequence may be of functional interest since gB induces a strong neutralizing antibody response. Congenitally infected infants had the highest degree of aa variability (14.5%) in this restricted fragment, while HIV-infected individuals had the lowest (1.6%), which allows us to speculate that a poor immune response might allow the dominance of few viral variants or that a high degree of selection pressure allows the survival of only a few strains. The functional importance of the frequent aa alterations within the regulatory MIE gene found in isolates from all patient populations remains to be determined.
In summary, optimal diagnosis of CMV infection by PCR in all patients can be achieved only if primer sequences with the potential to detect all CMV strains are used. The strategy of this study was to gather sequence information by assessing the nt sequence variations in independent clinical CMV isolates selected from four clinically different patient populations in order to identify conserved CMV sequences that can act as targets for primer selection. The DNA polymerase and gB gene regions proved to be more conserved and therefore presumably more suitable for primer selection for diagnostic PCR than the more variable MIE exon 4 gene region. The new PCR with POL primers is being evaluated with clinical samples obtained from different patient populations sent to the laboratory for diagnosis.
